The 5‐HT1Areceptor plays a significant rolein depression, anxiety, nausea, and emesis. Cannabidiolic acid (CBDA),a compound present in cannabis, shows therapeutic potential by act-ing through this receptor, but its low stability impedes its developmentas a medicine.
|Number of pages||2|
|Journal||British Journal of Pharmacology|
|Early online date||9 Jul 2019|
|Publication status||Published - Aug 2019|
|Event||British-Pharmacology-Society Meeting (Pharmacology) - London|
Duration: 18 Dec 2018 → 20 Dec 2018
Alcina, A. G., Stevenson, L. A., Haj, C., Smoum, R., Mechoulam, R., Hislop, J. N., & Pertwee, R. G. (2019). A synthetic analogue of cannabidiolic acid that acts like a positive allosteric modulator at 5-HT1A receptors. British Journal of Pharmacology, 176(16), 3011-3012. [OC011]. https://doi.org/10.1111/bph.14681